Replies to post #475842 on NorthWest Biotherapeutics Inc (NWBO)

[Rising_Sun]

Here's link to ClinicalTrials.gov updated with Primary/Secondary P3 Trial Goals:
https://clinicaltrials.gov/ct2/show/NCT00045968?term=DCVax-L&draw=2&rank=3

[Outcome Measures]

Primary Outcome Measures:
The primary objective of this study is to compare overall survival (OS) between patients randomized to DCVax-L and control patients from comparable, contemporaneous trials who received standard of care therapy only, in newly diagnosed glioblastoma. [ Time Frame: Until death ]

Secondary Outcome Measures:
The first secondary objective is to compare overall survival (OS) between patients randomized to placebo who received DCVax-L treatment following disease recurrence, and control patients from comparable, contemporaneous clinical trials, in recurrent GBM. [ Time Frame: Until death ]